Bronchiolitis in Pediatric Emergency

This is an acute viral lower respiratory infection. Varying definitions throughout the world cause confusion when doctors are assessing useful treatments. The etiological agent is usually respiratory syncytial virus but can also be adenovirus or parainfluenza 3.

The infection usually affects children under 1 year old. It occurs in about 10% of all infants and 2–3% are admitted to hospital. Younger infants are usually more seriously affected. The illness usually peaks on day 2–3 with resolution of wheeze and respiratory difficulty over 7–10 days. The cough may persist for weeks and postbronchiolitic respiratory symptoms may cause much concern. Management involves a primary assessment of severity and initiation of resuscitation and treatment. Assessment and management are illustrated in Table of Primary assessment and initial management of bronchiolitis in below.

Primary assessment and initial management of bronchiolitis
Primary assessment and initial management of bronchiolitis


History

The child presents with cough and wheezing. A lethargic, exhausted child may feed poorly, be hypoxemic, and is at risk of respiratory failure. Risk factors include age, infants with bronchopulmonary dysplasia or congenital heart disease. The time course is important. Is the child improving, stable, or likely to deteriorate over the next few days? Peak severity is usually at around day 2–3 of the illness. If the child is early on in the illness, consider admission to hospital.


Examination

Clinical signs include cough, tachypnea and hyperinflation. There may be audible wheeze. Auscultation reveals widespread crepitations and wheeze and signs of accessory muscle use. Cyanosis always indicates severe disease. Acyanotic infants may also be hypoxemic. If O2 saturation is less than 90%, the infant should receive supplementary O2 during the examination.


Investigations

A routine NPA (nasopharyngeal aspirate) or chest X-ray is not required for children with a typical clinical picture of bronchiolitis. If a chest Xray is taken it may demonstrate hyperinflation, peribronchial thickening, and often patchy areas of consolidation and collapse.

Consider whether this may be early asthma. Nebulized salbutamol may help in the older infant. Currently there is little evidence supporting the use of bronchodilators or antibiotics in bronchiolitis. Steroids were not thought to be of benefit, although some recent work from Toronto suggests that they may help.

Asthma in Pediatric Emergency

Acute asthma is one of the commonest reasons for presentation to an emergency department and admission to a hospital. Consider acute asthma when a child presents with signs of increased work of breathing, widespread wheezing and shortness of breath. There are other causes to consider such as Mycoplasma pneumonia, aspiration, inhaled foreign body, and cardiac failure. In the setting of a child with a previous history of asthma or when asthma seems the most likely diagnosis, then perform a primary assessment of severity and institute the initial resuscitation and treatment.


Primary assessment and initial resuscitation and management

Table below shows the clinical signs and management of asthma at varying degrees of severity. The arterial oxygen saturation (SaO2) may be reduced in the absence of significant airway obstruction by factors such as atelectasis and mucous plugging of airways. SaO2 is purely a measure of oxygenation, which may be preserved in the presence of deteriorating ventilation (with CO2 retention).

Consider transferring the child to a pediatric intensive care unit if the child:
• is in impending respiratory failure
• requires continuous nebulizers for >1 hour
• requires salbutamol more frequently than every 30 minutes after 2 hours
• is becoming exhausted.

Consider ventilation if:
• PCO2 is >8kPa
• there is persistent hypoxemia with PO2<8kPa in inspired oxygen of 60%
• there is increasing exhaustion despite emergency treatment.
Note that exhaustion, a silent chest, cyanosis, bradycardia and hypotension are preterminal signs.


Tables of Assessment and Management of Asthma in Pediatric


Tables of Assessment and Management of Asthma in Pediatric Mild degree
Mild Degree


Tables of Assessment and Management of Asthma in Pediatric Moderate degree
Moderate Degree


Tables of Assessment and Management of Asthma in Pediatric Critical degree
Critical Degree


Tables of Assessment and Management of Asthma in Pediatric Severe degree
Severe Degree

If poor response to i.v. salbutamol give aminophylline 10 mg/kgweight i.v. (maximum dose 250 mg) over 60 min.
Following loading dose, give continuous infusion (1–9 years: 1.1 mg/kgweight per hour, 10+ years: 0.7mg/kgweight per hour)
 See notes for indications for transfer to PICU

Note: If currently taking oral theophylline, do not give i.v. aminophylline in the Emergency Department—take serum level.
* Salbutamol 6 puffs if <6 years, 12 puffs if >6 years. Note nebulized salbutamol can also be used at a dose of 2.5–5 mg as described above.
** Ipratropium (Atrovent Forte 40 µg per puff) 2 puffs if < 6 years, 4 puffs if >6 years.



History

Inquire specifically about the duration and nature of symptoms, treatments used (relievers, preventers), trigger factors (including upper respiratory tract infection, allergy, passive smoking), pattern and course of previous acute episodes (e.g. admission or ICU admissions), parental understanding of the treatment of acute episodes, and the presence of interval symptoms (see the section on discharge below). Consider other causes of wheeze (e.g. bronchiolitis, mycoplasma, aspiration, foreign body).


Examination

The most important parameters in the assessment of the severity of acute childhood asthma are general appearance and mental state, and work of breathing (accessory muscle use, recession), as indicated in Table 5.1.
Initial SaO2 in air, heart rate and ability to talk are helpful but less reliable additional features. Wheeze intensity, pulsus paradoxus and peak expiratory flow rate are not reliable features. Lung function is hard to measure during an acute attack particularly if the child is tired, is young (<7 years) or if the child has not seen a peak flow meter orspirometer before; focus on the above signs in the assessment.Asymmetry on auscultation is often found due to mucous plugging, but might be due to a foreign body.


Investigation

Chest X-ray is not generally required (discuss with registrar/consultant if you are considering it). Arterial blood gas and spirometry are rarely required in the assessment ofacute asthma in children.

Discharge

Time spent planning a discharge either from the emergency department or the ward willreduce the likelihood of readmission and may also reduce morbidity. When you areorganizing discharge, consider the factors in Box  of Discharge pack below.

Discharge pack Asthma in Pediatric



Review need for preventative treatment

Consider preventative treatment, initially with inhaled steroids, if:
• Wheezing attacks are less than 6 weeks apart
• Attacks are becoming more frequent and severe
• Interval symptoms are increasing


Check inhaler technique

Emergency attendance or admission should provide the patient and family with the opportunity to use a spacer device and MDI. Make sure the child can use the device adequately and the child and family know the importance of using it for all preventative therapy and treatment for significant exacerbations.


Family education

On discharge from the Emergency Department or ward it is important that families understand the immediate management of their child’s asthma and care of spacers etc. It is not appropriate to educate them on all aspects of asthma during an acute episode. This is best reserved for a visit to an outpatient clinic or doctor’s rooms at a time more distant from the acute episode. A reasonable amount of time must be allocated and it is more likely that the information will be understood and retained. Go over the action plan and give the brief parent information handout.


Prescription

A prescription for all medications should be provided at the time of discharge. In mostcases this should include a prescription for a short course of prednisolone for a future attack. The use of this steroid supply should be discussed when the action plan is provided.


Follow up

All patients should have a clear follow up plan. For some it will be appropriate that they visit their general practitioner (GP) for an early review, particularly if their condition deteriorates or fails to improve significantly within 48 hours. At discharge all patients should have an outpatient appointment or appropriate follow up arranged with a pediatrician within 4–6 weeks. This visit will be used for medical review and, most importantly, appropriate education about asthma management.


Written action plan

All patients should have an individual written action plan and the discharging doctor should spend time going over the plan with the family.


Communicate with Medical Doctor

For every emergency attendance or discharge, there should be communication with the patient’s GP (general practitioner) or pediatrician. If possible this should be by fax, telephone or even email. The GP should receive a copy of the action plan.

Cardiac Failure and Congenital Heart Disease in Pediatric

Congenital heart disease may present as heart failure with or without shock or cyanosis. However, there are many causes of cardiac failure, including non-congenital reasons such as myocarditis. These may present with signs of heart failure, such as breathlessness, hepatomegaly, pallor and sweating, or may be severe enough to present as cardiogenic shock. Remember that heart failure in an infant can mimic bronchiolitis and the child may have contracted bronchiolitis. This in turn may be the precipitating cause of the heart failure. The likely causes are in picture below.

Causes of Cardiac Failure in Pediatric
Causes of Cardiac Failure in Pediatric


In infancy heart failure is usually secondary to congenital structural heart disease. As pulmonary pressures reduce after birth over the first few hours to days of life, increased pulmonary flow from lesions such as VSD or PDA will become apparent. These infants are likely to have a cardiac murmur audible. Rarer duct-dependent lesions, such as pulmonary atresia or transposition of the great vessels, will also present after a few days to weeks as the duct closes. These infants may have a large liver but may not have a cardiac murmur audible. Coarctation and severe aortic stenosis will also present as the duct closes.

Investigation

• CXR may be helpful to demonstrate cardiomegaly with pulmonary plethora or a
characteristic cardiac shape and size
• 12-lead ECG
• Cardiac echocardiography and cardiac consultation
• Infection screen as above
• 4-limb blood pressure


Management Shock 

If there are signs of shock then treat as in the cardiogenic shock section. Heart failure If the ventilation is adequate, then oxygen by facemask will be sufficient. However, if breathing is inadequate, intubation and artificial ventilation with PEEP will be required. 

If oxygenation improves with this maneuver, then the likely problem is that of pulmonary congestion secondary to increased flow from a VSD or PDA etc. A heart murmur may be heard and chest X-ray might be helpful in confirming the diagnosis (see below).

Treatment needs to be discussed with the cardiologists. It will include oxygenation and reducing the preload with diuretics (with, for example, frusemide 1 mg/kg i.v., repeated if no response after 2 hours). Consideration will be given to improving cardiac contractility (using, for example, digoxin or inotropes, such as dopamine or dobutamine) or decreasing the afterload with vasodilatation (using, for example, captopril).


Cyanosis

Increasing breathlessness and cyanosis in the first few days of life is the presentation of the rarer duct-dependent disease, such as tricuspid or pulmonary atresia. In theseconditions, oxygen may cause the duct to close further but, if it is considered necessary for ventilation, it should be carefully titrated. Intravenous prostaglandin El (0.01–0.1 µg/kg per min) should keep the duct open until cardiac opinion is available. Once aresponse occurs, the infusion rate should be titrated down. Prostaglandins may causeapnea and so the child should be ventilated during its administration.

All these children require careful monitoring by ECG, pulse oximetry and non-invasive blood pressure measurement. Remember to check blood pressure in lower limbs as well as upper limbs. It is essential to consider sepsis as a differential diagnosis of cardiacfailure in infancy and most infants will require a full infection screen and possible antibiotic cover. These children need admission and assessment by the cardiology team.

Cyanotic Episodes in Pediatric

Cyanotic episodes occur in children with cyanotic congenital heart disease, in particular tetralogy of Fallot and pulmonary atresia. There may be a previous history of squatting. The episodes usually occur early in the morning, or in the context of stress or dehydration with periods of increased oxygen demand or increased oxygen use. The pathophysiology is not fully understood, but relates to decreased pulmonary blood flow. Most episodes are self-limiting but cause hypoxic-ischemic brain injury or indeed may be fatal.

Assessment

The assessment includes consideration of the severity of the cyanosis or pallor with either distress and hyperpnea (not tachypnea), or lethargy and a depressed conscious state.
There may be evidence of structural heart disease occasionally with lessening or absence of a previously documented heart murmur.

Treatment and Management

This can be divided into initial measures for short periods of cyanosis and measures for more prolonged problems.

Initial measures
• Put the child in knee to chest position
• Give high flow oxygen via mask or headbox
• Avoid exacerbating distress
• Give morphine 0.2 mg kg−1 s.c.
• Do continuous ECG and oxygen saturation monitoring and frequent blood pressure
measurements
• Correct any underlying cause/secondary problems, which may exacerbate episode, e.g.
cardiac arrhythmia, hypothermia, hypoglycemia.

If the attack is prolonged
• Consult a pediatrician or a cardiologist
• Give intravenous fluids 10 ml/kg bolus followed by maintenance fluids
• Give sodium bicarbonate 2–3 mmol/kg  i.v. (ensure adequate ventilation)
• Consider admission

Kawasaki Disease in Pediatric

Kawasaki disease is a systemic vasculitis that predominantly affects children under 5 years old. Although the specific etiological agent remains unknown, it is believed that Kawasaki disease is a response to some form of infection (although it is not transmitted from person to person). Diagnosis is often delayed because the features are similar to those of many viral exanthems.


Strawberry tongue Kawasaki Disease in Pediatric
Strawberry tongue Kawasaki Disease in Pediatric

Diagnosis

The diagnostic criteria for Kawasaki disease are fever for 5 days or more, plus four out of five of the following:
• polymorphous rash
• bilateral (non-purulent) conjunctival infection
• mucous membrane changes, e.g. reddened or dry cracked lips, strawberry tongue, diffuse redness of oral or pharyngeal mucosa
• peripheral changes, e.g. erythema of the palms or soles, edema of the hands or feet, and in convalescence desquamation
• cervical lymphadenopathy (>15 mm diameter, usually unilateral, single, non-purulent and painful) and exclusion of diseases with a similar presentation: staphylococcal infection (e.g.scalded skin syndrome, toxic shock syndrome), streptococcal infection (e.g. scarlet fever, toxic shock-like syndrome not just isolation from the throat), measles, other viral exanthems, StevensJohnson syndrome, drug reaction and juvenile rheumatoid arthritis.

The diagnostic features of Kawasaki disease can occur sequentially and may not all be present at the same time. Moreover, it is recognised that some patients with Kawasaki disease do not develop sufficient features to fulfil the formal diagnostic criteria. Clinical vigilance and recognition of this possibility are necessary to recognise these ‘incomplete’ or ‘atypical’ cases. This is important because the atypical cases are probably at similar risk of coronary complications and require treatment. Other relatively common features include arthritis, diarrhea and vomiting, coryza and cough, uveitis, and gallbladder hydrops. Some patients get myocarditis.

Investigations

All patients should have the following investigations:
• ASOT/anti-DNAase B
• echocardiography (at least twice: at initial presentation and, if negative, again at 6–8 weeks)
• platelet count (marked thrombocytosis is common in second week of illness).
Other tests are not diagnostic or particularly useful. The following may be seen:
• neutrophilia
• raised ESR+CRP
• mild normochromic, normocytic anemia
• hypoalbuminemia
• elevated liver enzymes.

Thrombocytosis and desquamation appear in the second week of the illness or later. Their absence earlier does not preclude the diagnosis.

Management

Patients require admission to hospital if Kawasaki disease is diagnosed or strongly suspected. Intravenous immunoglobulin (2 g/kg over 10 hours) should be given, preferably within the first 10 days of the illness, but should also be given to patients diagnosed after 10 days of illness if there is evidence of ongoing inflammation, for instance with fever or raised ESR/CRP.
Aspirin (3–5 mg/kg once a day) should be given for at least 6–8 weeks. Some give a higher dose (10 mg/kg 8 hourly for the first few days) but this probably adds nothing over immunoglobulin.

Follow up

Pediatric follow up should be arranged on discharge. At least one further echocardiogram should be performed at 6–8 weeks. If this is normal, no further examinations are needed